Discern Money
Subscribe
  • Home
  • About Us
No Result
View All Result
Discern Money
  • Home
  • About Us
No Result
View All Result
Discern Money
No Result
View All Result
Home Type Curated

As Demand Grows, US Nuclear Energy Industry Faces Looming Crunch in Reactor Fuel Supply

by John Haughey, The Epoch Times
February 15, 2026
in Curated, News
0
Nuclear Power
118
SHARES
2k
VIEWS
Share on FacebookShare on Twitter

(The Epoch Times)—The Department of Energy (DOE) has invested billions in incentivizing domestic production of enriched uranium for the commercial development of advanced nuclear reactors, including $2.7 billion issued last month to three companies to build centrifuges and processing plants necessary to produce fuel for reactor cores.

Yet, a fuel crunch that could hobble President Donald Trump’s “nuclear renaissance” initiatives looms as soon as 2028, several experts warned during the two-day U.S. Nuclear Industry Council’s 13th annual Advanced Reactors Summit in Seattle that concluded Feb. 12.

Advisor Bullion Gold Surge

“If America wants to lead in advanced reactors, we have to do the nuclear fuel here. Make no mistake about that,” Centrus Energy Senior Vice President Patrick Brown told more than 400 nuclear industry professionals on Feb.12.

“Unfortunately, we’re really building from zero.”

Right now, he said, less than 1 percent of the nuclear fuel that the nation’s 94 commercial reactors annually consume is produced domestically, and that is exclusively dedicated to the Pentagon. The nation’s commercial nuclear energy industry is “completely reliant on foreign imports” of enriched uranium, he said, primarily from Kazakhstan and Canada.

Those imports include up to 5 percent from Russia that won’t be available soon. In response to Russia’s invasion of Ukraine in 2022, Congress in 2023 banned U.S. companies from importing Russian uranium. That ban goes into effect on Jan. 1, 2028.

Brown said with the global nuclear fuel market already constrained, domestic industry’s scramble to revive enrichment—a process American companies invented and once dominated—is now a race to have supply available to meet demand as new reactors come online.

Because that demand—spurred by the president’s May 2025 executive orders to license 10 new reactors by 2030 and quadruple commercial nuclear energy output by 2050—is likely to outpace domestic fuel production until the early 2030s, he said a timing shortage will emerge in 2028. 

“That’s when we’ll see that the problem is there’s not enough non-Russian supply” of enriched uranium to replace even the relatively small amount it now produces in a tight market where restrictions on one supplier impacts the entire market.

“Fortunately,” Brown said, the industry and the Trump administration recognize there is an approaching gap between burgeoning demand and static supply, and has deemed restoring domestic capacity to enrich uranium a national security priority akin to “a second Manhattan Project.”

Industry Must Respond

The nation’s domestic nuclear fuel supply chain got a $2.7 billion boost when the Department of Energy on Jan. 5 issued awards to three domestic companies to enrich low-enriched uranium and high-assay low-enriched uranium.

Securing $900 million awards each to build uranium enrichment plants are California-based General Matter in a former Paducah gaseous diffusion plant in western Kentucky, North Carolina-headquartered Orano Group’s Federal Services operation in Oak Ridge, Tennessee, and Maryland-based Centrus Energy’s uranium enrichment plant in Piketon, Ohio.

Brown said unlike the array of demonstration projects the Department of Energy is sponsoring, such as the Energy Reactor Pilot Program that has 10 companies vying for federal funding if they can demonstrate functionality of their designs by July 4, 2026, enriching uranium is not a new process.

“We’re not here to do science experiments, right?” he said. “We’re here to go big or go home. We’re not going home. The era of demonstration is over. We are moving onto large-scale commercial production.”



Centrus is already licensed to produce low-enriched uranium and high-assay low-enriched uranium in its Ohio plant, he said. Its Technology and Manufacturing Center in Oak Ridge, Tennessee, is the only domestic manufacturer of centrifuges needed for the enrichment process. It’s ready to gradually scale-up production.

“We have the site. We have the facility,” Brown said. “We have the room to expand” at the Piketon plant, which is demonstrating with 18 centrifuges what could be replicated by thousands. “Our technologies are proven and are actively producing [high-assay low-enriched uranium] today,” he said.

The Department of Energy award is designed to induce a long-term “demand signal” for investors and utilities, he said, by assuring them there will be ample domestic supply of enriched uranium available should they incorporate nuclear power into their grid expansion plans.

However, Brown said, the Piketon plant and other projects nationwide are not expected to reach peak production until the early 2030s, meaning there could be more demand than supply until production can catch up.

While the Department of Energy funding is critical in seeding domestic capacity to be self-sufficient in producing nuclear fuels, how swiftly that can be achieved is now up to the industry itself, he said, encouraging operators to begin negotiating “off take” agreements with Centrus and others engaged in uranium enrichment so they can secure their fuel supply and processors can commit to ramping up with confirmed orders.

“This is the chicken-and-the-egg problem that [the Department of Energy] was trying to solve. They said, ‘Build the capacity and the advanced reactor development will come while we’re building it,’” Brown said. “That’s the message. So we need firm contracts to proceed to build further. So let us know. We’re ready.”

336x280-1

JD's Links





Preparing for the Unexpected: Your Essential Partner in Health Readiness

In an increasingly unpredictable world—where supply chain disruptions, natural disasters, and global travel can leave us vulnerable to sudden health challenges—being prepared isn’t just smart; it’s essential.

That’s where Jase Medical steps in, offering innovative solutions that empower individuals and families to take control of their health with emergency medication kits designed for real-life scenarios. As someone who’s always advocated for proactive wellness, I was impressed by how Jase Medical combines expert medical guidance with convenient, customizable options to ensure you’re never caught off guard.

At the heart of their offerings is the Jase Case, a comprehensive emergency antibiotic kit priced at just $289.95. This powerhouse contains five life-saving antibiotics and five vital symptom-relief medications, capable of treating over 50 common infections—from respiratory issues and skin conditions to traveler’s diarrhea and more.

What sets it apart? It’s fully customizable with 28 add-on options, including a specialized KidCase for children ages 2-11, making it ideal for families.

Whether you’re stocking up for home emergencies or preparing for remote adventures, the Jase Case provides peace of mind with medications that boast extended shelf lives—up to five years or longer when stored properly, with studies showing 90% potency retention even after 20 years.

For those on the move, the Jase Go travel med kit at $129.95 is a game-changer. Curated by physicians, it addresses over 30 common travel ailments, from digestive upsets to minor injuries, ensuring explorers, hikers, and globetrotters can handle health hiccups without derailing their plans.

And for targeted concerns, Jase Medical offers specialized kits like the UTI Kit ($99.95), which includes test strips and treatments for urinary tract infections, vaginal candidiasis, and even jock itch, or the Parasites Kit (starting at $199.95), featuring compounded Ivermectin and Mebendazole to combat internal and external parasitic infections.

But Jase Medical isn’t just about one-off kits; their Jase Daily service provides an extended supply of your ongoing prescriptions, supporting hundreds of medications for chronic conditions like diabetes, heart health, high blood pressure, mental health, and more. This ensures long-term preparedness, safeguarding against factory shutdowns or extreme weather that could interrupt your regular supply.

The process couldn’t be simpler or more reassuring. Start by customizing your order online, then benefit from a thorough review by a team of world-class physicians who ensure safety and accuracy. In most cases, prescriptions are issued after a quick consultation—sometimes just a call to clarify allergies or needs—and your kit arrives discreetly at your door. While they don’t accept traditional health insurance, many customers use HSA cards, and refills are available for added convenience.

What truly stands out is the real-world impact. As radio host Glenn Beck puts it, “The supply lines for antibiotics already are stressed to the max. Please have some antibiotics on hand… You can do it through Jase.”

One satisfied customer shared, “It could have been a nightmare. Instead, the best trip we’ve had,” after their kit turned a potential health crisis into a minor blip during a family vacation.

In a time when health uncertainties loom larger than ever, Jase Medical isn’t just selling products—it’s delivering empowerment. Don’t wait for the next disruption; visit Patriot.TV/meds today to build your personalized emergency plan and step into a more secure tomorrow. Your health, and your family’s, deserves nothing less.

Tags: LedeNuclearThe Epoch TimesTop Story

Gold price by GoldBroker.com

  • About Us
  • Campaign: $10,000 Gold
  • Contact
  • Home
  • How to Take Full Advantage of the “Trump Economy” With Your Retirement Savings
  • Privacy Policy
© 2025 JD Rucker
No Result
View All Result
  • Home
  • Original
  • Curated
  • Aggregated
  • News
  • Opinions
  • Videos
  • Podcasts
  • About Us
  • Contact
  • Privacy Policy

© 2025 JD Rucker

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?